-
1دورية أكاديمية
المؤلفون: Swati Pal, Sumit Sen, Indrajit Nath, Arun Kumar, Utpal Kumar Biswas
المصدر: Asian Journal of Medical Sciences, Vol 12, Iss 4, Pp 24-30 (2021)
مصطلحات موضوعية: psoriasis, oxidative stress, malondialdehyde (mda), nitric oxide end product (nox), hs-crp, pasi (psoriasis area and severity index), Medicine
وصف الملف: electronic resource
Relation: https://www.nepjol.info/index.php/AJMS/article/view/33343; https://doaj.org/toc/2467-9100; https://doaj.org/toc/2091-0576
-
2
المؤلفون: Harish Suresh, Elena Keller, Deshan F. Sebaratnam, Helen Y. Sun
المصدر: JAAD International
مصطلحات موضوعية: medicine.medical_specialty, PBS, Pharmaceutical Benefits Scheme, Tildrakizumab, PASI75, 75% improvement from the initial Psoriasis Area and Severity Index Score, Pharmaceutical Benefits Scheme, risankizumab, PASI, Psoriasis Area and Severity Index, AUD, Australian dollar, ixekizumab, dermatologists, Psoriasis Area and Severity Index, adalimumab, tildrakizumab, Ustekinumab, medicine, health economics, biologic therapy, cyclosporine, BSC, best supportive care, Intensive care medicine, health care economics and organizations, Risankizumab, business.industry, cost-benefit analysis, Australia, cost-effectiveness analysis, cost-utility analysis, psoriasis, IL, interleukin, RCT, randomized-controlled trial, Quality-adjusted life year, guselkumab, CI, confidence interval, Ixekizumab, quality of life, QALY, quality-adjusted life years, Original Article, Secukinumab, WTP, willingness-to-pay, infliximab, ICUR, incremental cost-utility ratio, business, etanercept, TNF-α, tumor necrosis alpha, medicine.drug
-
3دورية أكاديمية
المؤلفون: Tzu-Chang Wang, Hsien-Yi Chiu, Ting-Shun Wang, Tsen-Fang Tsai
المصدر: Dermatologica Sinica, Vol 33, Iss 1, Pp 5-10 (2015)
مصطلحات موضوعية: adalimumab, biologics switch, etanercept, PASI (Psoriasis Area and Severity Index), psoriasis, ustekinumb, Dermatology, RL1-803
وصف الملف: electronic resource
-
4
المؤلفون: Merav Koschitzky, Maria Rosa Noliza F. Encarnacion, Ryan Rivera-Oyola, Kathryn Tan, Saakshi Khattri
المصدر: JAAD Case Reports, Vol 11, Iss, Pp 29-32 (2021)
JAAD Case Reportsمصطلحات موضوعية: medicine.medical_specialty, Dermatology, eczematous reaction, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Immune system, Psoriasis Area and Severity Index, Psoriasis, dupilumab, medicine, Case Series, biologics, Adverse effect, Th, T helper, atopic dermatitis, business.industry, Interleukin, Atopic dermatitis, psoriasis, AD, atopic dermatitis, medicine.disease, Dupilumab, EASI, eczema area and severity index, Discontinuation, IL, interleukin, PASI, psoriasis area and severity index, 030220 oncology & carcinogenesis, RL1-803, business
-
5
المؤلفون: Yuehong Xu, Sisi Cao, Kaiyue Yu, Yuanhao Zhai, Xiaoyuan Yang, Chuanbin Wu, Fengdie Yang, Yi Lu, Yixuan Wang, Xiuming Yu
المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 505-519 (2021)
Acta Pharmaceutica Sinica. Bمصطلحات موضوعية: PsA, psoriatic arthritis, Arthritis, PVP, polyvinyl pyrrolidone, 0302 clinical medicine, TEWL, transepidermal water loss, Blank-MN, blank layered MNs, General Pharmacology, Toxicology and Pharmaceutics, NSAIDs, nonsteroidal anti-inflammatory drugs, HA, hyaluronic acid, SC, stratum corneum, TNF-α, tumor necrosis factor α, 0303 health sciences, OCT, optical coherence tomography, Diclofenac Sodium, IMQ, imiquimod, Muscle atrophy, RhB, rhodamine B, 030220 oncology & carcinogenesis, Psoriatic arthritis, PDMS, polydimethylsiloxane, Original Article, medicine.symptom, NIC, nicotinamide, medicine.drug, Diclofenac sodium, medicine.medical_specialty, IVISR, in vivo imaging system, SEM, scanning electron microscope, CLSM, confocal laser scanning microscope, Urology, Tacrolimus, TAC-MN, layered MNs loading TAC in the inter-layer of needles, 03 medical and health sciences, Diclofenac, Psoriasis Area and Severity Index, Psoriasis, medicine, DIC-MN, layered MNs loading DIC in the tip-layer of needles, 030304 developmental biology, C6, coumarin 6, business.industry, DIC, diclofenac sodium, MIX-MN, unlayered MNs loading the mixture of DIC and TAC in needles, lcsh:RM1-950, Layered microneedles, medicine.disease, IL-17A, interleukin 17A, PASI, psoriasis area and severity index, lcsh:Therapeutics. Pharmacology, TD-MN, layered MNs co-loading TAC in the inter-layer of needles and DIC in the tip-layer, Need-based drug delivery, MN, microneedle, TAC, tacrolimus, business
-
6
المؤلفون: Roland Lichem, Alexandra Gruber-Wackernagel, Paul-Gunther Sator, Werner Saxinger, Hannes Trattner, Igor Vujic, Nina Häring, Constanze Jonak, Martina Schütz-Bergmayr, Robert R. Müllegger, Gudrun Ratzinger, Franz J. Legat, Wolfgang Weger, Clemens Painsi, Wolfram Hoetzenecker, Claudia Kölli, Alexander Mlynek, Knut Prillinger, Adrian Tanew, Angelika Hofer, Hans Skvara, Wolfgang Salmhofer, Christina Ellersdorfer, Franz Quehenberger, Barbara Gruber, Erich Schmiedberger, Thomas Graier, Peter Wolf
المصدر: JAAD International
مصطلحات موضوعية: Drug, medicine.medical_specialty, PP, per protocol, media_common.quotation_subject, Arthritis, apremilast, Dermatology, Intertriginous, LOCF, last observation carried forward, Psoriasis Area and Severity Index, drug survival, Internal medicine, Psoriasis, Medicine, media_common, business.industry, Hazard ratio, psoriasis, medicine.disease, HR, hazard ratio, PASI, psoriasis area and severity index, PsoRA, Psoriasis Registry Austria, Concomitant, Original Article, Apremilast, business, SD, standard deviation, medicine.drug
-
7
المؤلفون: Annunziata Raimondo, Luigi Ligrone, Carlo Marino, Serena Lembo, Giulia Guglielmi
المصدر: JAAD Case Reports, Vol 11, Iss, Pp 51-53 (2021)
JAAD Case Reportsمصطلحات موضوعية: vitiligo, medicine.medical_specialty, BSA, body surface area, Case Report, Vitiligo, Dermatology, PASI, Psoriasis Area and Severity Index, tumor necrosis factor α (TNF-α), Psoriasis Area and Severity Index, Psoriasis, medicine, Adalimumab, IL-17A, biologic therapy, TNF-α, tumor necrosis factor α, Body surface area, business.industry, DLQI, Dermatology Life Quality Index, Interleukin, Dermatology Life Quality Index, psoriasis, medicine.disease, IL, interleukin, Ixekizumab, RL1-803, business, medicine.drug
-
8
المؤلفون: Mirjam Fässler, Christoph Schlapbach
المصدر: JAAD Case Reports
Fässler, Mirjam; Schlapbach, Christoph (2020). Granuloma annulare arising under systemic psoriasis therapy successfully treated with adalimumab. JAAD case reports, 6(9), pp. 832-834. Elsevier 10.1016/j.jdcr.2020.07.013 <http://dx.doi.org/10.1016/j.jdcr.2020.07.013>
JAAD Case Reports, Vol 6, Iss 9, Pp 832-834 (2020)مصطلحات موضوعية: medicine.medical_specialty, 610 Medicine & health, Case Report, Dermatology, PASI, Psoriasis Area and Severity Index, Psoriasis Area and Severity Index, Psoriasis, adalimumab, medicine, Adalimumab, lcsh:Dermatology, biologics, Th, T helper, Granuloma annulare, TNF, tumor necrosis factor, treatment, business.industry, Th1, T helper 1, secukinumab, Interleukin, psoriasis, lcsh:RL1-803, medicine.disease, tumor necrosis factor-α inhibitor, IL, interleukin, T helper 1, granuloma annulare, GA, Granuloma annulare, Secukinumab, Tumor necrosis factor alpha, business, medicine.drug
وصف الملف: application/pdf
-
9
المؤلفون: Lyne Giroux, Arvin Ighani, Jensen Yeung, Jorge R. Georgakopoulos, Michelle Phung
المصدر: JAAD Case Reports, Vol 4, Iss 4, Pp 310-313 (2018)
JAAD Case Reportsمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Dermatology, PASI, Psoriasis Area and Severity Index, Article, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, dose optimization, Psoriasis Area and Severity Index, Psoriasis, lcsh:Dermatology, medicine, Dose escalation, Adverse effect, Series (stratigraphy), 030102 biochemistry & molecular biology, business.industry, secukinumab, psoriasis, lcsh:RL1-803, medicine.disease, Dose optimization, dose escalation, PGA, Physician Global Assessment, Secukinumab, business, AE, adverse event, PASI-75, 75% reduction from baseline PASI score
-
10
المؤلفون: Wilkinson, Nina, Tsakok, Teresa, Dand, Nick, Bloem, Karien, Duckworth, Michael, Baudry, David, Pushpa-Rajah, Angela, Griffiths, Christopher E.M., Reynolds, Nick J., Barker, Jonathan, Warren, Richard B., Burden, A. David, Rispens, Theo, Stocken, Deborah, Smith, Catherine
المصدر: Wilkinson, N, Tsakok, T, Dand, N, Bloem, K, Duckworth, M, Baudry, D, Pushpa-Rajah, A, Griffiths, C EM, Reynolds, N J, Barker, J, Warren, R B, Burden, A D, Rispens, T, Stocken, D & Smith, C 2019, ' Defining the therapeutic range for adalimumab and predicting response in psoriasis : a multicenter prospective observational cohort study ', Journal of Investigative Dermatology, vol. 139, no. 1, pp. 115-123 . https://doi.org/10.1016/j.jid.2018.07.028
The Journal of Investigative Dermatologyمصطلحات موضوعية: IMID, immune-mediated inflammatory disease, IBD, inflammatory bowel disease, Tumor Necrosis Factor-alpha, BADBIR, British Association of Dermatologists Biologic Interventions Registry, Adalimumab, RA, rheumatoid arthritis, Antibodies, Monoclonal, PASI, Psoriasis Area and Severity Index, Antibodies, Monoclonal, Humanized, Article, BSTOP, Biomarkers of Systemic Treatment Outcomes in Psoriasis, Etanercept, CI, confidence interval, PASI90, 90% improvement in baseline Psoriasis Area and Severity Index, Cohort Studies, PASI75, 75% improvement in baseline Psoriasis Area and Severity Index, Humans, Psoriasis, Prospective Studies, ADA, anti-drug antibody
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7fb02c669a37546deaa81518faf9005d
https://eprints.gla.ac.uk/212827/1/212827.pdf